Scott Galloway.
Professor of Marketing at NYU Stern School of Business, public speaker and entrepreneur
- Reports this week
- 1
- Active events
- 1
- Connections
- 23
What's happening
Active this week
One to three months ago
-
Scott Galloway critiques SpaceX's IPO valuation and recommends Eli Lilly, noting both companies are involved in the GLP-1 drug market.Well supported6 reports2 developments inside
-
Cathie Wood views SpaceX as a deep value play while Scott Galloway maintains opposing valuation views.Some support4 reports
-
Scott Galloway was appointed to the UC Board of Regents and used the platform to criticize the flaws in the US higher education system.Some support1 report
-
Scott Galloway criticized the New York City Mayor's tax list.Some support1 report2 developments inside
-
Scott Galloway predicts that SpaceX stock is currently overvalued, following reports on its performance traded on the Nasdaq exchange via CNBC.Some support1 report
-
Scott Galloway is a professor at New York University.Some support1 report
Gone quiet
No new reports in 90+ days-
Scott Galloway warned of market shifts due to obesity and noted Eli Lilly is gaining FDA approval for weight management.Some support1 report
-
Scott Galloway discussed the newly introduced pied-à-terre tax for the City of New York on a podcast, criticizing the tax list's unintended consequences.Some support1 report1 development inside
-
Scott Galloway, who lives in Florida, supported the pied-à-terre tax introduced for the City of New York.Some support1 report
-
Scott Galloway and Kara Swisher hosted a podcast discussing political targets and doxxing.Some support1 report
-
Scott Galloway shared his philosophy on LinkedIn's podcast.Some support2 reports
-
Scott Galloway criticized Lesley Stahl's continued presence on 60 Minutes and offered investment advice regarding Donald Trump.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Scott Galloway this week
News at the entities that move Scott Galloway most-
New York University StructuralThe FDA is involved in regulating drug approvals for GLP-1 Receptor Agonists.Moves Scott Galloway
-
Elon Musk OperationalUkraine relies heavily on SpaceX tools, while Europe is actively seeking to reduce its dependence on US technology.Moves Scott Galloway
-
supreme court Mentioned togetherThe Supreme Court will consider a Trump executive order, which the ACLU argues bypasses protections passed by Congress.Moves Scott Galloway
-
Gavin Newsom StructuralAndrew was involved in a murder plot while Camacho pleaded guilty in Brownsville, and Newsom's clemency affects US policy.Moves Scott Galloway
-
Eli Lilly and Company Mentioned togetherEli Lilly is building a new facility in Pennsylvania, with Governor Shapiro attending the groundbreaking ceremony.Moves Scott Galloway
-
Donald Trump Mentioned togetherOfficials met with Donald Trump to discuss an aviation incident caused by aging air traffic control infrastructure.Moves Scott Galloway
Connections
The 16 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Gavin Newsom Structural
Scott Galloway was appointed to the UC Board of Regents, a governing body operating within the state system overseen by Gavin Newsom's domain.
-
Elon Musk Operational
Galloway publicly critiques Musk's status as an innovator, and Musk has retaliated against Galloway, causing him to sell assets.
-
Kara Swisher Operational
They co-host a podcast where they discuss current events, political targets, and doxxing topics.
-
New York University Structural
Scott Galloway holds a formal academic position as a professor at New York University.
-
Lesley Stahl Operational
Galloway publicly criticized Stahl regarding her continued presence on 60 Minutes.
-
Pivot Operational
Scott Galloway and Pivot are co-hosts of the Pivot podcast, discussing media trends.
-
Substack Operational
Scott Galloway co-hosts a podcast utilizing the Substack platform.
-
Eli Lilly and Company Mentioned together
Scott Galloway publicly analyzes and recommends Eli Lilly as a strong investment choice based on its market success.
Show all 16 connections
-
SpaceX Mentioned together
Scott Galloway provides expert commentary and critiques on SpaceX's market performance and valuation.
-
supreme court Mentioned together
Scott Galloway discusses and comments on the economic implications of Supreme Court rulings.
-
Donald Trump Mentioned together
Galloway commented on Trump, suggesting that Trump's continued success is a favorable investment thesis.
-
City of New York Shared context
Galloway frequently comments on and provides commentary regarding specific policies and political figures associated with the City of New York.
-
OpenAI Mentioned together
Scott Galloway publicly commented on the need for new leadership at OpenAI.
-
Nebius Group Mentioned together
Scott Galloway provides commentary and analysis regarding Nebius Group.
-
Charles Lindbergh Mentioned together
Scott Galloway references Charles Lindbergh's historical actions when discussing modern figures.
-
New York City Shared context
Scott Galloway offers critical commentary regarding New York City's municipal tax policies.
History
Events by the month they beganNovember 2026
1 eventSeptember 2026
2 eventsAugust 2026
7 events- Scott Galloway criticized the New York City Mayor's tax list.
- Scott Galloway predicts that SpaceX stock is currently overvalued, following reports on its performance traded on the Nasdaq exchange via CNBC.
- Scott Galloway is a professor at New York University.
- Scott Galloway warned of market shifts due to obesity and noted Eli Lilly is gaining FDA approval for weight management.
- Scott Galloway discussed the newly introduced pied-à-terre tax for the City of New York on a podcast, criticizing the tax list's unintended consequences.
- Scott Galloway, who lives in Florida, supported the pied-à-terre tax introduced for the City of New York.
- Scott Galloway and Kara Swisher hosted a podcast discussing political targets and doxxing.
Show 1 earlier month
June 2026
3 events- Scott Galloway critiques SpaceX's IPO valuation and recommends Eli Lilly, noting both companies are involved in the GLP-1 drug market.
- Scott Galloway shared his philosophy on LinkedIn's podcast.
- Scott Galloway criticized Lesley Stahl's continued presence on 60 Minutes and offered investment advice regarding Donald Trump.